NCT05261438View on ClinicalTrials.gov

Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

May 1, 2021

Study Completion Date

September 15, 2021

Conditions
Non-squamous NSCLC
Trial Locations (1)

410013

Hunan Cancer Hospital, Changsha

All Listed Sponsors
lead

Hunan Province Tumor Hospital

OTHER

NCT05261438 - Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC | Biotech Hunter | Biotech Hunter